Method of treatment with anti-CD2 antibody LO-CD2b

Details Method of treatment with anti-CD2 antibody LO-CD2b Method of treatment with anti-CD2 antibody LO-CD2b

2007-07-31

2007-07-31

Gambel, Phillip (Department: 1644)

Drug, bio-affecting and body treating compositions

Immunoglobulin, antiserum, antibody, or antibody fragment,...

Monoclonal antibody or fragment thereof

C424S144100, C424S130100, C424S133100, C530S387100, C530S388200

Reexamination Certificate

active

10288977

ABSTRACT:
A monoclonal antibody which binds to baboon and human CD2, and in particular LO-CD2b antibody. The antibody may be employed to prevent and inhibit an immune response in human patients, such as when the immune response is mediated by the activation and proliferation of T-cells or natural killer cells.

REFERENCES:
patent: 5239062 (1993-08-01), Blattler et al.
patent: 5730979 (1998-03-01), Bazin et al.
Dehoux et al., Transplantation, Jun. 27, 2000;69(12):2622-33.
Beckman-Coulter Immunology online catalog, 2007, pp. 1-4.
Ritchie et al., Urol Res. 1982;10(5):221-6.
Meuer et al., Cell. Apr. 1984;36(4):897-906.

Affiliated with

Also associated with

Rating

Method of treatment with anti-CD2 antibody LO-CD2b does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of treatment with anti-CD2 antibody LO-CD2b, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treatment with anti-CD2 antibody LO-CD2b will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3736400